IL-2 and heat shock protein 70 (HSP70) improves NK cell homing within the tumor site in vivo51, which suggests that the administration of IL-15/HSP70/IL-2-treated NK cells may be a promising therapeutic approach to be considered in the treatment of brain tumors. The gene discussed is IL2; the disease is brain neoplasm.